logo

503B Compounding Pharmacy

The Pharmacy Times® 503B Compounding Pharmacy Resource Center is a comprehensive resource for clinical news and expert insights on issues related to compounding pharmacies and drug safety.

Latest News

How Microbial Preservation Supports Quality and Safety in Compounding Pharmacies
How Microbial Preservation Supports Quality and Safety in Compounding Pharmacies

April 4th 2025

Mark Mulvahill, MBA, MSc, discusses the importance of microbial preservation and reference materials in pharmaceutical manufacturing and compounding pharmacies, highlighting their role in contamination control, regulatory compliance, and enhancing microbiological testing reliability.

Navigating FDA Compounding Regulations: Tirzepatide's Removal From the Shortage List and Its Impact on 503A and 503B Facilities
Navigating FDA Compounding Regulations: Tirzepatide's Removal From the Shortage List and Its Impact on 503A and 503B Facilities

November 1st 2024

Clinicians, Pharmacists Should Work to Ensure Safety Compounded GLP-1 Medications
Clinicians, Pharmacists Should Work to Ensure Safety Compounded GLP-1 Medications

October 23rd 2024

Tirzepatide, FDA, Drug Shortage, Lawsuit | Image Credit: Cynthia - stock.adobe.com
Outsourcing Facilities Association Sues FDA Over Sudden Removal of Tirzepatide From Drug Shortage List

October 14th 2024

503B, 503A, compounding pharmacy
Regulatory Considerations Regarding the 503B to 503A Compounding Model For Community Pharmacies

June 26th 2024

More News